Effects of Early Integrated Palliative Care on Caregivers of Patients with Lung and Gastrointestinal Cancer: A Randomized Clinical Trial

About this course

Released: 12/13/2017

Expires: 12/13/2019

Instructions

Read the following information before beginning the educational activity and click the "Take this course" link at the bottom of the page

Study the educational activity

Complete the CME quiz and evaluation

After successful completion of the CME quiz and evaluation, you will receive the credit or participation certificate

*The CME quiz and evaluation must be completed by December 13, 2019 in order to receive the credit or participation certificate.

Target Audience

Physicians who wish to advance their current knowledge of symptom management and supportive care.

Learning Objectives

Discuss the ways cited by the article in which the benefits of early integrated palliative care extend beyond patient outcomes and positively impact the experience of caregivers.

Accreditation and Credit Designation

The Society for Translational Oncology is accredited by the ACCME to provide continuing medical education for physicians.

The Society for Translational Oncology designates this journal-based CME activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Disclosure Policy

In compliance with the ACCME Standards of Commercial Support, it is the policy of the Society for Translational Oncology to ensure balance, independence, objectivity, and scientific rigor in all of its educational activities and to include information free of commercial bias and based on the best evidence available. All individuals in a position to influence the content of this activity have disclosed relevant financial interests or relationships of their own, their spouse/partner, or their worksite, with manufacturers or providers of commercial products, services, technology, or programs; and disclosed relationships with current non-governmental supporters of the activity.

All information is submitted and reviewed and found to be scientifically rigorous, based on the best available evidence, fair and balanced, and free of commercial bias. All the recommendations involving clinical medicine in this CME activity are based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the care of patients. All scientific research referred to, reported or used in CME in support or justification of a patient care recommendation conforms to the generally accepted standards of experimental design, data collection and analysis.

Any potential conflicts of interests are resolved via The Oncologist's anonymous peer review process: http://authors.theoncologist.com/conflicts-of-interest. All manuscripts are reviewed by the Editorial Board with ad hoc assistance from two or more external experts in the field. All final publication decisions are made by the Editorial Board. The acceptance of a manuscript is based on its originality and importance to the field as assessed by the Editors.

Disclosures

No one who was in control of the content of this activity has relevant financial relationships with ACCME-defined commercial interests.

Commercial Support

The Editors are grateful for an educational grant from Merrimack in partial support of our Journal CME Program.